Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorGülsoy, Kemal Yetiş
dc.contributor.authorOrhan, Semiha
dc.date.accessioned2023-11-15T08:25:08Z
dc.date.available2023-11-15T08:25:08Z
dc.date.issued2023en_US
dc.identifier.citationGulsoy, K. Y., & Orhan, S. (2023). The effect of C-reactive protein, Procalcitonin and Neutrophil/lymphocyte ratio on mortality in patients hospitalized in the intensive care unit. Medicine Science, 12(2).en_US
dc.identifier.issn2147-0634
dc.identifier.urihttps://dx.doi.org/10.5455/medscience.2022.07.169
dc.identifier.urihttps://hdl.handle.net/20.500.12933/1753
dc.description.abstractEffectiveness of using inflammatory markers for prognosis assessment in the intensive care units (ICU) is still not clear. The current study aimed to examines the relationship among procalcitonin, C-reactive protein, and neutrophil/lymphocyte ratio of patients who are getting treatment in the ICU during hospitalization and mortality. The study was carried out with a total of 788 patients who were hospitalized in the ICU longer than a day. All participants were over the age of 18 years old. C-reactive protein, procalcitonin, and neutrophil/lymphocyte ratios were compared between the groups of those who died and those who were discharged from the ICU.54.6% (n= 430) of 788 patients who were admitted to the study, were male whereas45.4% (n= 358) of them were female. The median age of the study group was calculated as 79 years (IQR = 19 years) (P<0,001). The univariate Cox regression analysis performed to examine the parameters affecting mortality, the analysissuggested following P-values for the procalcitonin, C-reactive protein, and neutrophil/lymphocyte ratio; <0.001, 0.887, and 0.014 respectively. Conversely, the multivariate Cox regression analysis which is performed to examine the parameters affecting mortalityyielded following P-valuesfor the same variables respectively: 0.242, 0.116, and 0.523. Although inflammatory markers (i.e.,C-reactive protein, procalcitonin, and neutrophil/lymphocyte ratios) were high in patients who died, their relationship with mortality in the ICU could not be shown.en_US
dc.language.isoengen_US
dc.publisherEffect Publishing Agency ( EPA )en_US
dc.relation.isversionof10.5455/medscience.2022.07.169en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleThe effect of C-reactive protein, Procalcitonin and Neutrophil/lymphocyte ratio on mortality in patients hospitalized in the intensive care uniten_US
dc.typearticleen_US
dc.authorid0000-0003-2617-6197en_US
dc.departmentAFSÜen_US
dc.contributor.institutionauthorOrhan, Semiha
dc.identifier.volume12en_US
dc.identifier.issue2en_US
dc.identifier.startpage383en_US
dc.identifier.endpage388en_US
dc.relation.journalMedicine Scienceen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster